Dx Antibodies

Aus coViki
Version vom 27. Juni 2020, 08:56 Uhr von Ossip Groth (Diskussion | Beiträge)
(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
Wechseln zu: Navigation, Suche


32428207 2020. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.


32320384 2020. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
32323974 ä. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay
32343948 2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
32357209 ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection
32337590 ä. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
32221519 ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
32306047 ä. Antibody Detection and Dynamic Characteristics in Patients with COVID-19
32357808 2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
32267220 2020. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients
32363011 2020. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2
32350047 2020. The Role of Antibody Testing for SARS-CoV-2: Is There One?
32209385 ä. Profile of specific antibodies to SARS-CoV-2: The first report
32277023 2020. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays
32301750 2020. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
32301749 2020. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
32229605 2020. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
32227490 ä. Performance of VivaDiag COVID?19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID?19 in acute patients referring to emergency room department
32329979 2020. COVID-19 rapid antibody cassette point of care tests: practical considerations
32335175 ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report
32335168 ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients =}}
32330303 2020. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test
32330291 2020. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience
32320064 2020. Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2)
32313159 2020. Will antibody tests for the coronavirus really change everything?
32364358 2020. A specifikus IgM- es IgG-antitesteket detektalo gyorstesztek erteke a SARS CoV-2 virusfertozes kimutatasaban (A COVID-19-pandemia orvosszakmai kerdesei)
32382418 2020. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
32247384 2020. Developing antibody tests for SARS-CoV-2
32387968 2020. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
32350462 2020. Antibody responses to SARS-CoV-2 in patients with COVID-19
32301958 2020. The Promise and Peril of Antibody Testing for COVID-19
32243608 ä. Detection of antibodies against SARS?CoV?2 in patients with COVID?19
32104917 ä. Development and clinical application of a rapid IgM?IgG combined antibody test for SARS?CoV?2 infection diagnosis
32198501 ä. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
32466975 ä. Rapid immunoglobulin test confirms a suspected case of COVID-19
32510168 2020. Clinical performance of different SARS-CoV-2 IgG antibody tests.
32349966 2020. Covid-19: Antibody test that claims to be 99% accurate is certified by EU.
32398876 2020. A serological assay to detect SARS-CoV-2 seroconversion in humans.
32505774 2020. SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.
32473021 2020. Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests.
32461288 2020. Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2.
32412044 2020. Antibody Testing for COVID-19.
32355546 2020. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.
32438677 2020. Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis.
32473953 2020. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.
32439655 2020. Covid-19: Two antibody tests are "highly specific" but vary in sensitivity, evaluations find.
32459191 2020. Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department.
32447328 2020. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody.
32472684 2020. Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.
32504735 2020. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
32442248 2020. Testing for Novel Covid-19 antibodies: a necessary adjunct.
32531475 2020. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection.
32302069 2020. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.
32343598 2020. Serological tests for COVID-19 antibodies: Limitations must be recognized.
32400364 2020. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples.
32485155 2020. Comparison of the Elecsys(R) Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
32526218 2020. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
32485620 2020. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
32479758 2020. SARS-CoV-2 Antibody Testing - Questions to be asked.
32505777 2020. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
32458479 2020. Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.
32381641 2020. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
32431052 2020. SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.
32443459 2020. Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data.
32270436 ä. Detection of serum IgM and IgG for COVID-19 diagnosis
32389784 ä. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
32389405 ä. Understanding Antibody Testing for COVID-19
32358955 ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection
32484887 2020. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies.
32427334 2020. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.
32386187 2020. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.
32467977 2020. Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan.
32383254 2020. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples.


32403010 2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies


32251798 2020. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis